The characterization of specific mutations in epigenetic modifiers, such as DNMT3A, IDH2, and TET, in histone markers and in different subtypes of PTCL is essential to understanding how these mutations affect the epigenetic landscape and gene expression. The gene discussed is IDH2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.